Last Update Time:
N/A
ISIN:
INE602K01014
Sector:
PHARMA
Symbol:
SYNCOM
Syncom Healthcare Limited
₹0.00
₹0.00
(0.00%)
▲
Prev. Close
₹N/A
Open
₹0.00
Close
₹4.20
Range
₹0.00 - ₹0.00
High
₹0.00
Low
₹0.00
Ind. Close
₹0.00
VWAP
₹0.00
The current stock price of Syncom Healthcare Limited is ₹0.00, with a target price range between ₹0.00 and ₹0.00. The stock has experienced a price change of ₹0.00 (0.00%), reflecting recent market volatility.
Today's opening price was ₹0.00, while the previous close stood at ₹0.00.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Syncom Healthcare Limited Price Chart
Syncom Healthcare Limited Pre Open Market Overview: N/A
Key Metrics:
- IEP (Indicative Equilibrium Price): 0.00
- Previous Close Price: 0.00
- Change: 0.00%
- Total Traded Volume: 0.00
- Total Buy Quantity: 0.00
- Total Sell Quantity: 0.00
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 0.00 | 0.00 | 0.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 0.00
Total Sell Quantity: 0.00
Shareholding Patterns of Syncom Healthcare Limited
Key Trade Statistics of Syncom Healthcare Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | N/A |
| Traded Value (₹ Cr.) | N/A |
| Total Market Cap (₹ Cr.) | N/A |
| Free Float Market Cap (₹ Cr.) | N/A |
| Impact cost | N/A |
| Quantity Traded | N/A |
| Deliverable Quantity | N/A |
| % of Quantity to Traded | N/A |
| Security VaR | N/A |
| Index VaR | N/A |
| VaR Margin | 100 |
| Extreme Loss Rate | N/A |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 100 |
| Face Value | 10 |
Key Price Statistics of Syncom Healthcare Limited
The 52-week high for Syncom Healthcare Limited was ₹0.00, recorded on N/A. On the other hand, the 52-week low stands at ₹0.00, with the lowest value recorded on N/A.
The upper band for trading is ₹4.35, and the lower band is ₹3.95. The price band is No Band%.
The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.00.
| Price Information | Details |
|---|---|
| 52 Week High (-) | 0.00 |
| 52 Week Low (-) | 0.00 |
| Upper Band | 4.35 |
| Lower Band | 3.95 |
| Price Band (%) | No Band |
| Daily Volatility | - |
| Annualised Volatility | - |
| Tick Size | 0.00 |
Key Securities Statistics of Syncom Healthcare Limited
| Securities Information | Details |
|---|---|
| Status | Temporary Suspended |
| Trading Status | Suspended |
| Date of Listing | 15-Feb-2010 |
| Adjusted P/E | NA |
| Symbol P/E | NA |
| Index | NA |
| Macro-Economic Sector | HEALTHCARE |
| Sector | PHARMA |
| Industry | PHARMACEUTICALS |
| Basic Industry | PHARMACEUTICALS |
Security Status of Syncom Healthcare Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Syncom Healthcare Limited
| Subject | Date |
|---|---|
| Corporate Insolvency Resolution Process | 23-Sep-2021 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 16-Aug-2021 |
| Copy of Newspaper Publication | 16-Aug-2021 |
| Outcome of Board Meeting | 14-Aug-2021 |
| Financial Results Updates | 14-Aug-2021 |
| Financial Result Updates | 14-Aug-2021 |
| Clarification - Financial Results | 14-Jul-2021 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 08-Jul-2021 |
Corporate Actions of Syncom Healthcare Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting | 22-Dec-2020 |
| 10 | Annual General Meeting | 20-Sep-2019 |
| 10 | Annual General Meeting | 19-Sep-2018 |
| 10 | Annual General Meeting | 20-Sep-2017 |
| 10 | Annual General Meeting | 21-Sep-2016 |
| 10 | Annual General Meeting | 21-Sep-2015 |
| 10 | Annual General Meeting | 19-Sep-2014 |
| 10 | Annual General Meeting | 25-Sep-2013 |
| 10 | Annual General Meeting | 24-Sep-2012 |
| 10 | Annual General Meeting | 23-Sep-2011 |
| 10 | Annual General Meeting | 29-Jul-2010 |
Board Meetings of Syncom Healthcare Limited
Financial Results of Syncom Healthcare Limited
Company Directory of Syncom Healthcare Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.syncomhealthcare.in | Head Office/ Corporate Office | Syncom Healthcare Limited 114-116, Trade House 14/3, South Tukoganj Indore | INDORE |
| www.syncomhealthcare.in | Registered Office | F44, 1st Floor Shagun Arcade CHS, A K Vaidya Marg, Opp HDFC Bank, Malad East, | MUMBAI |
| www.syncomhealthcare.in | Transfer Agent | Link Intime India Private Limited C-101, 247 Prak, L.B.S. Marg Vikhroli West | MUMBAI |
Insider Trading of Syncom Healthcare Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | PRATEEK BANKDA | 7096632 | Sell |
| 7(2) | PRATEEK BANKDA | 6948000 | Sell |
| 7(2) | PRATEEK BANKDA | 0 | Buy |
| 7(2) | PRANAV BANKDA | 0 | Sell |
| 7(2) | PRATEEK BANKDA | 14312611 | Sell |
| 7(2) | Mr. Ajay Shankarlal Bankda | 37303236 | Sell |
| 7(2) | Mrs. Jyoti Bankda | 20754606 | Sell |
| 7(2) | Mrs. Pratik Bankda | 29028924 | Buy |
| 7(2) | Mr. Pranav Bankda | 29028918 | Buy |
Annual Reports of Syncom Healthcare Limited
Investor Complaints of Syncom Healthcare Limited
Event Calendar of Syncom Healthcare Limited
| Purpose | Details |
|---|---|
| Results/Others | To transact various business including to consider the Directors Report to the members, Audited Financial Results for the year ended March 31, 2010, etc. |
| Board meeting Rescheduled | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on November 15, 2011 interalia, to consider and approve the unaudited financial results of the Company for the quarter ended September 30, 2011. The Company has now informed the Exchange that aforesaid Board Meeting has been rescheduled and will now be held on November 14, 2011. |
| Results | Inter-alia, to consider and take on record the Un-audited Financial Results of the Company for the quarter ended December 31, 2012. |
| Results | Interalia, to consider and approve the audited Financial Results of the Company for the quarter and year ended March 31, 2013. |
| Results | Interalia, to consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2013. |
| Results | Interalia, to consider and approve the Unaudited Financial results of the Company for the quarter & half year ended September 30, 2013. |
| Results/Others | The agenda of the Meeting would be as under : (1) To read and confirm the Minutes of previous Board Meeting. (2) To approve the un-audited quarterly financial results of the Company for the Quarter and Nine Months ended December 31, 2013. (3) To adopt quarterly secretarial audit report for the quarter ended December 31, 201. (4) Any other matter with the permission of the Chairman. |
| Results/Others | (1) To read and confirm the Minutes of previous Board meeting. (2) To take on record of Audited Financial Result of the Company for the Quarter and Financial Year ended March 31, 2014. (3) To adopt quarterly secretarial audit report for the quarter ended 31st March 2014. (4) Any other matter with the permission of the Chairman. Further, as per the Company's Code of Conduct for Prevention of Insider Trading read with Securities Exchange Board of India (Prohibition of Insider Trading) Regulation, 1992, the 'Trading window' for dealing in Equity Shares of the Company shall remain closed from May 19, 2014 to May 31, 2014 (both days inclusive) for the purpose of declaration of Audited Financial Result for the Quarter and Year ended March 31, 2014 for all Directors/Officers/Designated Employees of the Company. The 'Trading window' shall reopen for dealing in securities in the Equity shares of the Company from the start of the business hours on June 2, 2014. |
| Results/Others | Inter alia, to consider the following: 1. To take on record of un-audited Financial Result of the Company for the Quarter ended June 30, 2014. 2. To adopt quarterly secretarial audit report for the quarter ended 30 June, 2014, 3. To approve the Directors Report and Corporate Governance Report. 4. To fix date for closure of Register of Members and Share Transfer Books. 5. To decide date, venue and time of the 12th Annual General Meeting. 6. To Appoint Scrutinizer for the purpose of E-voting. 7. To appoint Practicing Company Secretary for Secretarial Audit for the FY14-15. |
| Results | Interalia, to consider and approve the unaudited Financial results of the Company for the quarter and half year ended September 30, 2014. |
| Results | interalia, to consider and approve the unaudited Financial results of the Company for the quarter ended December 31, 2014. |
| Results | Interalia, to consider and approve the audited Financial results of the Company for the quarter and year ended March 31, 2015. |
| Results/Others | Interalia, to transact the following business:1. To approve the Unaudited financial results of the Company for the quarter ended June 30, 2015.2. To approve the Directors Report and Corporate Governance Report.3. To decide date, venue and time of the Annual General Meeting.4. To approve the Notice for calling of the Annual General Meeting.5. To fix date for closure of Register of Members and Share Transfer Books.6. To deal with any other businesses which may be placed before the Board. |
| Results | Interalia, to consider and approve the unaudited Financial Results of the Company for the quarter and half year ended September 30, 2015. |
| Results/Others | interalia, to consider and approve the unaudited Financial results of the Company for the quarter ended December 31, 2015 along with limited review report and any others matters with the permission of the chair. |
| Results | inter-alia to consider the following business:1. To approve and consider the Audited Financial Results along with Statement of Assets and Liabilities for the financial year ended March 31, 2016 |
| Results | Inter-alia, to consider the following business:1. To approve the Un-audited Financial Results of the Company for the first quarter ended on June 30, 2016. |
| Results | Inter alia, to consider and approve the unaudited Financial Results along with statement of Assets and Liabilities for second quarter ended September 30, 2016. |
| Others | inter alia to consider the following business: (1) To appoint Mr Ajay Shankarlal Bankda as an Additional Director of the Company.(2) T designate Mr Ajay Shankarlal Bankda as Managing Director of the Company.(3) To fix the date of Extra-Ordinary General Meeting and to consider and approve the draft notice of Extra-Ordinary General Meeting of the Company.(4) To fill the Casual Vacancy of Statutory Auditor. (5) To initate the process of closure of Subsidiary. |
| Results | Inter-alia to consider and take on record the unaudited financial results of the Company for the quarter and nine months ended December 31, 2016 (Q3). |
| Results | Inter-alia to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended on March 31, 2017 (Q4) alongwith the Statement of Assets and Liabilities for the half year ended March 31, 2017 and to take on record Auditor s Report thereon. |
| Results | inter-alia to:- 1). Consider and Approve the Standalone and Consolidated Audited Financial Results of the Company for the 1st quarter (Q1) ended on June 30, 2017 2). To Consider the Book Closure date for the 15th Annual General Meeting to be held on September 29, 2017. . |
| Results | Inter-alia to consider and approve the standalone unaudited financial results of the Company for the quarter and half year ended on September 30, 2017 (Q2). |
| Results/Others | inter-alia (1).To consider and approve the standalone unaudited financial results of the Company for the quarter and nine months ended on December 31, 2017 (Q3). (2)To consider the appointment of Mr. Bhishampal Singh Yadav as an additional whole time Director. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results | SYNCOM : 29-May-2018 : The Company had informed the Exchange that a Board meeting to be held on May 28, 2018 To consider and approve the financial results for the period ended March 31, 2018. the Company has now inform the exchange that the meeting is postponed and Scheduled to be held on May 29, 2018, inter alia to consider and take on record the Audited Financial Results for the fourth quarter and year ended March 31, 2018. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results | SYNCOM : 30-May-2019 : The Company has informed the Exchange that a Board meeting to be held on May 29, 2019 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2019, To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | SYNCOM : 14-Aug-2019 : The Company has informed the Exchange that a Board meeting to be held on August 13, 2019 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 14, 2019, To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | SYNCOM : 16-Nov-2019 : The Company has informed the Exchange that a Board meeting to be held on November 14, 2019 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 16, 2019, To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | Intimation of Board Meeting - Un-Audited Standalone Financial Results for the quarter and half year ended September 30, 2019. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | SYNCOM : 23-Jun-2020 : The Company has informed the Exchange that a Board meeting to be held on Jun 22, 2020 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on Jun 23, 2020, To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Other business matters | This is to inform you that Resolution Professional has called for the meeting of the Company which will be held on Monday 7th December, 2020 at registered office of the Company at F44, 1st Floor Shagun Arcade CHS, A K Vaidya Marg, Opp HDFC Bank, Malad East, Mumbai 400097 to consider, approve the Annual Report of the Company for the Financial Year 2019-20 and any other business/matters as may be permitted by the Resolution Professional.This is for your information and records. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Financial Results | To consider and approve the un audited financial results for the period ended Jun 30, 2021 |
Share Transfers of Syncom Healthcare Limited
Voting Results of Syncom Healthcare Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 30-DEC-2020 | AGM | ADOPTION OF FINANCIAL STATEMENTS. |
| 30-DEC-2020 | AGM | RATIFICATION OF REMUNERATION OF COST AUDITOR |
| 30-DEC-2020 | AGM | RETIFICATION OF APPOINTMENT OF M/S. BHATTER AND COMPANY, CHARTERED ACCOUNTANTS AS STATUTORY AUDITORS TO HOLD OFFICE FOR FY 2020-21 AND TO FIX REMUNERATION |
| 30-DEC-2020 | AGM | APPOINTMENT OF A DIRECTOR IN PLACE OF MR. AJAY SHANKARLAL BANKDA (DIN: 00013796) WHO RETIRES BY ROTATION AND, BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENT |
| 30-SEP-2019 | AGM | Adoption of Financial Statements |
| 30-SEP-2019 | AGM | APPOINTMENT OF MR. AJAY SHANKARLAL BANKDA (DIN: 00013796) AS A DIRECTOR LIABLE TO RETIRE BY ROTATION.nn |
| 30-SEP-2019 | AGM | APPOINTMENT OF M/S. BHATTER & COMPANY, CHARTERED ACCOUNTANT AS STATUTORY AUDITOR OF THE COMPANY |
| 30-SEP-2019 | AGM | RATIFICATION OF REMUNERATION OF COST AUDITOR |
| 30-SEP-2019 | AGM | REGULARIZATION OF APPOINTMENT OF MR. MANOJ NEGI AS EXECUTIVE DIRECTOROF THE COMPANY |
| 30-SEP-2019 | AGM | APPOINTMENT OF MR.BHISHAMPAL SINGH YADAV (DIN 07017046) AS NON EXECUTIVE INDEPENDENT DIRECTOR OF THE COMPANY |
| 30-SEP-2019 | AGM | SELLING OR DISPOSING OFF ASSETS/ UNDERTAKINGS OF THE COMPANY AND / OR CREATION OF SECURITY |
FAQs on Syncom Healthcare Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.